Microtubule Inhibitor [EPC]

165857 reported adverse events

Drugs of this class: PACLITAXEL DOCETAXEL DOCETAXEL ANHYDROUS PACLITAXEL PROTEIN-BOUND PARTICLES PACLITAXEL (AIBUMIN-BOUND) TIRBANIBULIN

These side effects are most commonly reported by patients taking drugs of the Microtubule Inhibitor [EPC] class:

# Side effect Count
0 ALOPECIA 18607
1 DIARRHOEA 10118
2 NAUSEA 9100
3 NEUTROPENIA 8608
4 OFF LABEL USE 7661
5 DYSPNOEA 7433
6 FATIGUE 7226
7 MALIGNANT NEOPLASM PROGRESSION 6969
8 ANAEMIA 6889
9 MADAROSIS 6742
See all common reactions for Microtubule Inhibitor [EPC]

Drugs of the Microtubule Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAIR DISORDER 5637 0.6834
1 MADAROSIS 6742 0.5803
2 HAIR COLOUR CHANGES 5883 0.4723
3 HAIR TEXTURE ABNORMAL 5997 0.4479
4 MYELOSUPPRESSION 6184 0.1715
5 PERIPHERAL SENSORY NEUROPATHY 948 0.1620
6 METASTASES TO LYMPH NODES 890 0.1317
7 NEUTROPENIC SEPSIS 832 0.1164
8 METASTASES TO BONE 1804 0.1098
9 POLYNEUROPATHY 1276 0.1065
See all enriched reactions for Microtubule Inhibitor [EPC]